Published in Biopolymers on November 01, 2013
Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci (2015) 1.24
Mini review: linkage between α-Synuclein protein and cognition. Transl Neurodegener (2015) 0.77
Amyloid-like assembly of the low complexity domain of yeast Nab3. Prion (2015) 0.77
What amyloid ligands can tell us about molecular polymorphism and disease. Neurobiol Aging (2016) 0.77
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease. Neurobiol Aging (2016) 0.77
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Alzheimer's disease. N Engl J Med (2010) 13.13
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 9.53
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A (2005) 8.60
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Alzheimer's disease. N Engl J Med (2004) 7.50
1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR (1995) 7.43
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A (2009) 6.87
Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
An improved broadband decoupling sequence for liquid crystals and solids. J Magn Reson (2000) 4.94
Alzheimer's disease: the challenge of the second century. Sci Transl Med (2011) 4.88
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
The physical basis of how prion conformations determine strain phenotypes. Nature (2006) 4.77
Trans-synaptic spread of tau pathology in vivo. PLoS One (2012) 4.53
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J Exp Med (2012) 3.98
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci (2009) 3.68
Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol (2009) 3.55
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest (2011) 3.53
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol (2010) 3.49
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A (2009) 3.47
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40
Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem (2002) 3.37
Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol (2010) 3.34
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23
Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol (2004) 3.05
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol (2011) 2.94
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem (2011) 2.86
Resolving controversies on the path to Alzheimer's therapeutics. Nat Med (2011) 2.78
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice. J Neurosci (2000) 2.41
Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry (2002) 2.37
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A (2009) 2.27
Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol (2007) 2.18
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci (2005) 2.17
Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A (2009) 2.15
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A (2009) 2.14
The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci (2010) 2.10
Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry (1995) 2.05
The seeds of neurodegeneration: prion-like spreading in ALS. Cell (2011) 2.03
Preventing Alzheimer's disease. Science (2012) 1.94
Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J Mol Biol (1992) 1.90
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A (2011) 1.82
A diversity of assembly mechanisms of a generic amyloid fold. Mol Cell (2011) 1.80
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci (2006) 1.77
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β. Nature (2012) 1.77
Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J Mol Biol (2010) 1.74
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med (2009) 1.70
Inducible proteopathies. Trends Neurosci (2006) 1.67
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med (2009) 1.65
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils. Proc Natl Acad Sci U S A (2012) 1.60
Prion-like spread of protein aggregates in neurodegeneration. J Exp Med (2012) 1.49
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol (2009) 1.42
Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc Natl Acad Sci U S A (2011) 1.39
Exploiting amyloid fibril lamination for nanotube self-assembly. J Am Chem Soc (2003) 1.37
Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion (2009) 1.35
Transmission of mouse senile amyloidosis. Lab Invest (2001) 1.34
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers. Mol Neurodegener (2010) 1.34
Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One (2010) 1.25
Amyloid-beta membrane binding and permeabilization are distinct processes influenced separately by membrane charge and fluidity. J Mol Biol (2008) 1.22
Review: model peptides and the physicochemical approach to beta-amyloids. J Struct Biol (2000) 1.18
Membrane and surface interactions of Alzheimer's Aβ peptide--insights into the mechanism of cytotoxicity. FEBS J (2011) 1.17
Alzheimer's disease and the amyloid β-protein. Prog Mol Biol Transl Sci (2012) 1.16
PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging (2009) 1.15
Prion-like aggregates: infectious agents in human disease. Trends Mol Med (2010) 1.13
Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions. J Mol Biol (2005) 1.12
Direct observation of nucleation and growth in amyloid self-assembly. J Am Chem Soc (2010) 1.10
Structural evolution of Iowa mutant β-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J Am Chem Soc (2011) 1.10
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc Natl Acad Sci U S A (2007) 1.10
Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides (2002) 1.07
Compensation for pulse imperfections in rotational-echo double-resonance NMR by composite pulses and EXORCYCLE. J Magn Reson (2004) 1.07
Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des (2012) 1.06
Facial symmetry in protein self-assembly. J Am Chem Soc (2008) 1.05
Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging (2008) 1.05
Cross-strand pairing and amyloid assembly. Biochemistry (2008) 0.97
Peptides organized as bilayer membranes. Angew Chem Int Ed Engl (2010) 0.94
Regulation of amyloid precursor protein cleavage. J Neurochem (1999) 0.94
Infectivity of amyloid diseases. Trends Mol Med (2002) 0.93
Corruption and spread of pathogenic proteins in neurodegenerative diseases. J Biol Chem (2012) 0.93
Modulating amyloid self-assembly and fibril morphology with Zn(II). J Am Chem Soc (2006) 0.93
Metal effects on the membrane interactions of amyloid-beta peptides. Eur Biophys J (2008) 0.90
Lipid matrix plays a role in Abeta fibril kinetics and morphology. FEBS Lett (2011) 0.88
Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key? Amino Acids (2002) 0.86
The expanding realm of prion phenomena in neurodegenerative disease. Prion (2009) 0.86
Structural origin of polymorphism of Alzheimer's amyloid β-fibrils. Biochem J (2012) 0.85
Propagation of the prion phenomenon: beyond the seeding principle. J Mol Biol (2012) 0.85
Boltzmann statistics rotational-echo double-resonance analysis. J Phys Chem B (2007) 0.85
Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods. FASEB J (2006) 0.85
Endosomal accumulation of GM1 ganglioside-bound amyloid beta-protein in neurons of aged monkey brains. Neuroreport (2007) 0.83
Controlling amyloid growth in multiple dimensions. Amyloid (2006) 0.81
Remodeling cross-β nanotube surfaces with peptide/lipid chimeras. Angew Chem Int Ed Engl (2012) 0.81
Cholesterol and Clioquinol modulation of A beta(1-42) interaction with phospholipid bilayers and metals. Biochim Biophys Acta (2007) 0.81
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature (2013) 3.55
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol (2011) 2.94
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A (2009) 2.27
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics (2002) 1.75
Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci (2011) 1.66
Research funding. Science funding and short-term economic activity. Science (2014) 1.57
Competencies: a cure for pre-med curriculum. Science (2011) 1.47
MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol (2007) 1.45
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol (2009) 1.42
The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2004) 1.42
The response of the aged brain to stroke: too much, too soon? Curr Neurovasc Res (2007) 1.39
Exploiting amyloid fibril lamination for nanotube self-assembly. J Am Chem Soc (2003) 1.37
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol (2010) 1.34
Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol (2008) 1.27
DNA-catalyzed polymerization. J Am Chem Soc (2002) 1.25
Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem (2011) 1.21
Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett (2008) 1.19
PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging (2009) 1.15
Direct observation of nucleation and growth in amyloid self-assembly. J Am Chem Soc (2010) 1.10
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc Natl Acad Sci U S A (2007) 1.10
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest (2011) 1.10
Environmental pH sensing: resolving the VirA/VirG two-component system inputs for Agrobacterium pathogenesis. J Bacteriol (2005) 1.07
Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des (2012) 1.06
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol (2011) 1.06
Facial symmetry in protein self-assembly. J Am Chem Soc (2008) 1.05
Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging (2008) 1.05
Aβ seeds resist inactivation by formaldehyde. Acta Neuropathol (2014) 1.03
Semagenesis and the parasitic angiosperm Striga asiatica. Plant J (2007) 1.01
Chemical biology of multi-host/pathogen interactions: chemical perception and metabolic complementation. Annu Rev Phytopathol (2004) 1.00
The innate immunity of maize and the dynamic chemical strategies regulating two-component signal transduction in Agrobacterium tumefaciens. ACS Chem Biol (2006) 0.98
Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis. Acta Neuropathol (2012) 0.97
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev (2009) 0.97
Cross-strand pairing and amyloid assembly. Biochemistry (2008) 0.97
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. J Neurochem (2004) 0.95
Peptides organized as bilayer membranes. Angew Chem Int Ed Engl (2010) 0.94
Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci (2008) 0.94
Integration of rotation and piston motions in coiled-coil signal transduction. J Bacteriol (2007) 0.93
Real-time quantitative analysis of lipid disordering by aurein 1.2 during membrane adsorption, destabilisation and lysis. Biochim Biophys Acta (2010) 0.93
Integrating input from multiple signals: the VirA/VirG two-component system of Agrobacterium tumefaciens. Chembiochem (2004) 0.93
Modulating amyloid self-assembly and fibril morphology with Zn(II). J Am Chem Soc (2006) 0.93
Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions. J Biol Chem (2007) 0.92
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease. Acta Neuropathol (2006) 0.92
Amyloid by default. Nat Neurosci (2011) 0.91
Membrane interactions of antimicrobial peptides from Australian frogs. Biochim Biophys Acta (2008) 0.91
Phase evolution of Na2O-Al2O3-SiO2-H2O gels in synthetic aluminosilicate binders. Dalton Trans (2016) 0.90
Metal switch for amyloid formation: insight into the structure of the nucleus. J Am Chem Soc (2002) 0.90
Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers. Biochemistry (2007) 0.88
Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2008) 0.88
Lipid matrix plays a role in Abeta fibril kinetics and morphology. FEBS Lett (2011) 0.88
Nucleobase-directed amyloid nanotube assembly. J Am Chem Soc (2008) 0.87
Templating molecular arrays in amyloid's cross-beta grooves. J Am Chem Soc (2009) 0.87
Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta). Alzheimer Dis Assoc Disord (2004) 0.86
Addressing the problems of base pairing and strand cyclization in template-directed synthesis: a case for the utility and necessity of 'molecular midwives' and reversible backbone linkages for the origin of proto-RNA. Chem Biodivers (2007) 0.86
The receiver domain of hybrid histidine kinase VirA: an enhancing factor for vir gene expression in Agrobacterium tumefaciens. J Bacteriol (2010) 0.86
Ratcheting up vir gene expression in Agrobacterium tumefaciens: coiled coils in histidine kinase signal transduction. Chembiochem (2002) 0.86
Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol (2002) 0.85
SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval. J Vis Exp (2010) 0.85
The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier. Curr Pharm Des (2011) 0.85
Dynamics and fluidity of amyloid fibrils: a model of fibrous protein aggregates. J Am Chem Soc (2002) 0.85
Constitutive activation of two-component response regulators: characterization of VirG activation in Agrobacterium tumefaciens. J Bacteriol (2006) 0.85
Kinetic intermediates in amyloid assembly. J Am Chem Soc (2014) 0.84
Intercalation as a means to suppress cyclization and promote polymerization of base-pairing oligonucleotides in a prebiotic world. Proc Natl Acad Sci U S A (2010) 0.83
Light harvesting antenna on an amyloid scaffold. Chem Commun (Camb) (2008) 0.83
The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors. Bioorg Med Chem Lett (2008) 0.83
Disentanglement of heterogeneous dynamics in mixed lipid systems. Biophys J (2011) 0.83
Ovarian aging in squirrel monkeys (Saimiri sciureus). Reproduction (2009) 0.83
Macroscale assembly of peptide nanotubes. Chem Commun (Camb) (2007) 0.82
Nonenzymatic ligation of DNA with a reversible step and a final linkage that can be used in PCR. Chembiochem (2012) 0.81
Controlling amyloid growth in multiple dimensions. Amyloid (2006) 0.81
Remodeling cross-β nanotube surfaces with peptide/lipid chimeras. Angew Chem Int Ed Engl (2012) 0.81
Cholesterol and Clioquinol modulation of A beta(1-42) interaction with phospholipid bilayers and metals. Biochim Biophys Acta (2007) 0.81
Peptide membranes in chemical evolution. Curr Opin Chem Biol (2009) 0.81
Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Mech Ageing Dev (2004) 0.81
Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI. J Alzheimers Dis (2011) 0.80
Branched signal wiring of an essential bacterial cell-cycle phosphotransfer protein. Structure (2013) 0.80
Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol. ACS Nano (2010) 0.80
Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study. Biochemistry (2009) 0.80
Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42). Biochim Biophys Acta (2007) 0.80
Interactions of a synthetic Leu-Lys-rich antimicrobial peptide with phospholipid bilayers. Eur Biophys J (2011) 0.80
Adenine Synthesis in a Model Prebiotic Reaction: Connecting Origin of Life Chemistry with Biology. J Chem Educ (2011) 0.80
Digital and analog chemical evolution. Acc Chem Res (2012) 0.80
Phase networks of cross-β peptide assemblies. Langmuir (2012) 0.79
Copper(II)-bis-histidine coordination structure in a fibrillar amyloid β-peptide fragment and model complexes revealed by electron spin echo envelope modulation spectroscopy. Chembiochem (2013) 0.79
A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain. J Neurochem (2014) 0.79
The grandmother effect and the uniqueness of the human aging phenotype. Gerontology (2009) 0.79
A practical implementation of de-Pake-ing via weighted Fourier transformation. PeerJ (2013) 0.78
Dye-release assay for investigation of antimicrobial peptide activity in a competitive lipid environment. Eur Biophys J (2014) 0.78
Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy. Epilepsia (2005) 0.78
The American science pipeline: sustaining innovation in a time of economic crisis. CBE Life Sci Educ (2010) 0.78
Parasitic angiosperms, semagenesis and general strategies for plant-plant signaling in the rhizosphere. Pest Manag Sci (2009) 0.78